KAPA
Kairos Pharma Ltd · NYSE MKT LLC · Biotechnology
$0.59$-0.03 (-5.47%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for KAPA is being prepared.
Key Stats
Key Stats
Open
$0.60
Day High
$0.60
Day Low
$0.58
Prev Close
$0.62
Volume
0
Avg Volume
94.5K
Day Change
$-0.03
Change %
-5.47%
Fundamentals
Fundamentals
P/B
2.33
EPS (TTM)
$-0.30
Market Cap
$13M
52-Wk Range
$0.40 — $2.11
Who Owns This Stock
Who Owns KAPA
Other38.5%10 holders
Tactical / Macro37.6%1 holder
Passive / Index23.9%2 holders
Based on Q4 2025 13F filings + AC behavioral model
14 institutional holders
Top Holders
$228.4B
$66.7B
0.0%$48.2B
+8.1%$47.9B
-6.0%$45.4B
$34.4B
0.0%$31.9B
0.0%$31.4B
$17.1B
$10.8B
$9.3B
-91.5%$3.8B
$3.0B
-63.4%$58M
-76.8%$37M
$15M
$14M
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Moderate Selling Pressure
Other(38.5%)
●
—Tactical / Macro(37.6%)
◄◄
Reducing rapidlyPassive / Index(23.9%)
●
HoldsDealer / Bank(0.0%)
●
Facilitating24% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus8 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows10 increased/new, 4 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of KAPA on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.